Wednesday, December 03, 2014 6:07:43 PM
Amphastar Pharmaceuticals, Inc. (AMPH) is a specialty pharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well. These positive earnings estimate revisions suggest that analysts are becoming more optimistic on AMPH’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Amphastar Pharmaceuticals could be a solid choice for investors.Current Quarter Estimates for AMPH In the past 30 days, 1 estimate has gone higher for Amphastar Pharmaceuticals while none has gone lower in the same time period. The trend has been pretty favorable too, with loss estimates narrowing down from 11 cents a share 30 days ago, to 6 cents today, a move of over 45.5%.Current Year Estimates for AMPH Meanwhile, Amphastar Pharmaceuticals’ current year figures are also looking quite promising, with 1 estimate moving higher in the past month, compared to 1 moving lower. The loss estimate trend has also seen a boost for this time frame, narrowing down from 16 cents per share 30 days ago to 14 cents per share today, an improvement of 12.5%.Bottom Line The stock has also started to move higher lately, adding 6.5% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #2 (Buy) stock to profit in the near future.
TRADING TNA AND TZA
http://investorshub.advfn.com/TRADING-TNA-AND-TZA-12981/
Recent AMPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:49:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:47:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:29:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:54:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 10:51:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 01:35:23 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 09:06:09 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 09:53:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:38:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:21:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 12:37:11 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 09:03:55 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/23/2024 04:53:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 09:37:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 11:27:18 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/10/2024 09:25:31 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/09/2024 09:22:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/08/2024 09:23:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:25:01 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2024 09:07:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 11:25:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:49:41 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/01/2023 09:11:38 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/17/2023 05:34:17 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM